Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to -$9.5 million.

  • PROCEPT BioRobotics' Free Cash Flow rose 5010.5% to -$9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$79.7 million, marking a year-over-year increase of 2301.55%. This contributed to the annual value of -$103.6 million for FY2024, which is 2221.1% up from last year.
  • Per PROCEPT BioRobotics' latest filing, its Free Cash Flow stood at -$9.5 million for Q3 2025, which was up 5010.5% from -$17.8 million recorded in Q2 2025.
  • Over the past 5 years, PROCEPT BioRobotics' Free Cash Flow peaked at -$9.5 million during Q3 2025, and registered a low of -$41.3 million during Q1 2023.
  • In the last 5 years, PROCEPT BioRobotics' Free Cash Flow had a median value of -$18.8 million in 2025 and averaged -$22.4 million.
  • Per our database at Business Quant, PROCEPT BioRobotics' Free Cash Flow crashed by 12208.05% in 2023 and then soared by 5022.69% in 2024.
  • Quarter analysis of 5 years shows PROCEPT BioRobotics' Free Cash Flow stood at -$16.8 million in 2021, then tumbled by 60.23% to -$26.9 million in 2022, then fell by 24.42% to -$33.5 million in 2023, then decreased by 0.17% to -$33.6 million in 2024, then skyrocketed by 71.69% to -$9.5 million in 2025.
  • Its Free Cash Flow stands at -$9.5 million for Q3 2025, versus -$17.8 million for Q2 2025 and -$18.8 million for Q1 2025.